Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Obesity Science & Practice|November 10, 2025
The Identification of Potential Treatment Targets to Reduce the Risk of Obesity-Related Complications: A Step Toward a Treat-to-Target Approach in Obesity ManagementLuca Busetto, Volker Schnecke, Maria Overvad, et al.
Advances in Therapy|July 28, 2025
Body Mass Index Progression, Development of Complications and Healthcare Costs Over 8 Years in UK Individuals Living With Overweight/ObesityLuca Busetto, Silvia Capucci, João D da Rocha Fernandes, et al.
Diabetes, Obesity & Metabolism|September 11, 2023
Association between weight loss and health care resource utilization in adults living with obesity: Evidence from a UK primary care databaseChris Bojke, Silvia Capucci, Christiane Lundegaard Haase, et al.
Obesity Science & Practice|July 28, 2026
Mapping Obesity Care Pathways and Healthcare Resource Use From 2015 to 2019 in EnglandAlexander Dimitri Miras, Silvia Capucci, Sylwia Migas, et al.
Clinical Obesity|November 25, 2024
Healthcare utilization associated with obesity management in Ontario, CanadaSean Wharton, Adel Belloum, Maria Luckevich, et al.
Nature Communications|October 8, 2021
Temporal evolution of master regulator Crp identifies pyrimidines as catabolite modulator factorsIda Lauritsen, Pernille Ott Frendorf, Silvia Capucci, et al.
International Journal of Obesity (2005)|September 18, 2023
Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individualsJonathan Pearson-Stuttard, Tania Banerji, Silvia Capucci, et al.
Molecular Therapy. Methods & Clinical Development|August 2, 2019
Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1Edmund G Wee, Nathifa A Moyo, Kevin O Saunders, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2022
Erratum: Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1Edmund G Wee, Nathifa A Moyo, Kevin O Saunders, et al.
Endocrine Connections|March 9, 2026
Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UKThomas van Sloten, Steven H J Hageman, Jan Westerink, et al.
Pageof 3